Novo Nordisk A/S annual net income for fiscal TTM was $122.0 billion, an increase of 19.1% from $102.4 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $122.0B | $102.4B | $101.0B | $83.7B | $55.5B | $47.8B | $42.1B | $39.0B | $38.6B | $38.1B | $37.9B | $34.9B | $26.5B | $25.2B | $21.4B | $17.1B | $14.4B | $10.8B | $9.7B | $8.5B | $6.5B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $48.6B | $26.9B | $20.0B | $26.5B | $29.0B | $28.2B | $27.3B | $20.1B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More NVO metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All NVO financial statements → Interactive NVO charts →
About TickerBase · Data methodology & sources